Insufficient Growth At GC Biopharma Corp. (KRX:006280) Hampers Share Price
You may think that with a price-to-sales (or “P/S”) ratio of 0.9x GC Biopharma Corp. (KRX:006280) is definitely a stock worth checking out, seeing as almost half of all the Biotechs companies in Korea have P/S ratios greater than 17.3x and even P/S above 63x aren’t out of the ordinary. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the highly reduced P/S.
View our latest analysis for GC Biopharma
